Netrins promote developmental and therapeutic angiogenesis

Science

Volumn 313, Issue 5787, 2006, Pages 640-644

  Wilson, Brent D ^a,b   Ii, Masaaki ^c,d   Park, Kye Won ^a   Suli, Arminda ^a   Sorensen, Lise K ^b   Larrieu Lahargue, Fréderic ^a   Urness, Lisa D ^a,b   Suh, Wonhee ^a,e   Asai, Jun ^c   Kock, Gerhardus A H ^c,f   Thorne, Tina ^c   Silver, Marcy ^c   Thomas, Kirk R ^a,b   Chien, Chi Bin ^a,b   Losordo, Douglas W ^c   Li, Dean Y ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^e Samsung Medical Center   (South Korea)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; NEUROLOGY; PHYSIOLOGICAL MODELS; PROTEINS; RNA;

ENDOTHELIAL CELLS; NEOVASCULARIZATION; NETRINS; THERAPEUTIC ANGIOGENESIS;

NEUROMUSCULAR REHABILITATION;

MESSENGER RNA; NETRIN; RECEPTOR;

FINFISH; PROTEIN; RNA;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; ENDOTHELIUM CELL; GENE; GENE REPRESSION; IN VITRO STUDY; ISCHEMIA; NERVE FIBER; NETRIN1A GENE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; VASCULAR DISEASE; VERTEBRATE; ZEBRA FISH;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL LINE; CELL MOVEMENT; CHEMOTAXIS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DNA, COMPLEMENTARY; EMBRYO, NONMAMMALIAN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; ISCHEMIA; MICE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; NEURAL CONDUCTION; RECEPTORS, CELL SURFACE; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

DANIO RERIO; MURINAE; VERTEBRATA;

EID: 33746878254     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1124704     Document Type: Article

References (33)

1. M. Klagsbrun, A. Eichmann, Cytokine Growth Factor Rev. 16, 535 (2005).
2. P. Carmeliet, M. Tessier-Lavigne, Nature 436, 193 (2005).
3. A. Ekhmann, F. Le Noble, M. Autiero, P. Carmeliet, Curr. Opin. Neurobiol. 15, 108 (2005).
4. B. M. Weinstein, Cell 120, 299 (2005).
5. T. Serafini et al., Cell 78, 409 (1994).
6. K. Hong et al., Cell 97, 927 (1999).
7. V. Corset et al., Nature 407, 747 (2000).
8. E. Stein, Y. Zou, M.-m. Poo, M. Tessier-Lavigne, Science 291, 1976 (2001).
9. F. Cebria, P. A. Newmark, Development 132, 3691 (2005).
10. R. D. Madison, A. Zomorodi, G. A. Robinson, Exp. Neurol. 161, 563 (2000).
11. K. Srinivasan, P. Strickland, A. Valdes, G. C. Shin, L. Hinck, Dev. Cell 4, 371 (2003).
12. W. Yebra et al., Dev. Cell 5, 695 (2003).
13. K. W. Park et al., Proc. Natl. Acad. Sci. U.S.A. 101, 16210 (2004).
14. X. Lu et al., Nature 432, 179 (2004).
15. Y. Yin, J. R. Sanes, J. H. Miner, Mech. Dev. 96, 115 (2000).
16. M. Koch et al., J. Cell Biol. 151, 221 (2000).
17. H. Arakawa, Nat. Rev. Cancer 4, 978 (2004).
18. P. Mehlen, C. Furne, Cell. Mol. Life Sci. 62, 2599 (2005).
19. N. D. Lawson, B. M. Weinstein, Dev. Biol. 248, 307 (2002).
20. J. D. Lauderdale, N. M. Davis, J. Y. Kuwada, Mol. Cell. Neurosci. 9, 293 (1997).
21. S. Isogai, N. D. Lawson, S. Torrealday, M. Horiguchi, B. M. Weinstein, Development 130, 5281 (2003).
22. T. Couffinhal et al., Am. J. Pathol. 152, 1667 (1998).
23. A. Kawamoto et al., Circulation 110, 1398 (2004).
24. J. P. Reilly et al., J. Intern. Cardiol. 18, 27 (2005).
25. P. Schratzberger et al., J. Clin. Investig. 107, 1083 (2001).
26. D. W. Losordo et al., Circulation 105, 2012 (2002).
27. D. H. Walter et al., Circulation 110, 36 (2004).
28. M. Ii et al., Circulation 112, 93 (2005).
29. Y. S. Yoon et al., Circulation 111, 2073 (2005).
30. Diabetes Control and Complications Trial Research Group, Ann. Intern. Med. 122, 561 (1995).
31. UK Prospective Diabetes Study Group, Lancet 352, 837 (1998).
32. T. Murohara et al., J. Clin. Investig. 101, 2567 (1998).
33. We thank K. Whitehead, P. Lindblom, and H. Gerhardt for technical expertise and assistance; I. Shepherd, L. Hinck, and D. Grunwald for reagents; the Mass Spectroscopy Core Facility at the University of Utah; and D. Lim for graphics. D.Y.L. is supported by grants from NIH, American Cancer Society, American Heart Association (AHA), Flight Attendants Medical Research Institute, and Burroughs Wellcome Fund. C.B.C. is supported by grants from NIH. D.W.L. is supported by grants from NIH and AHA. B.D.W. is an American College of Cardiology Foundation/Pfizer Fellow in Cardiovascular Medicine.